Dexcom Inc
(DXCM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 101,100 | -127,100 | -50,200 | -65,600 | -57,600 |
| Depreciation Amortization | 48,700 | 29,100 | 16,100 | 15,000 | 10,800 |
| Income taxes - deferred | 200 | -2,200 | N/A | N/A | N/A |
| Accounts receivable | -60,000 | -93,200 | -31,800 | -27,200 | -31,700 |
| Other Working Capital | 6,100 | -40,900 | 2,600 | -6,300 | -24,400 |
| Other Operating Activity | 218,400 | 357,500 | 155,300 | 140,300 | 151,900 |
| Operating Cash Flow | $314,500 | $123,200 | $92,000 | $56,200 | $49,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -180,000 | -67,100 | -66,000 | -55,700 | -33,300 |
| Net Acquisitions | N/A | -11,300 | N/A | 300 | -500 |
| Purchase Of Investment | -2,030,400 | -452,500 | -171,800 | -39,200 | -45,200 |
| Sale Of Investment | 1,196,400 | 392,100 | 93,400 | 38,700 | 27,500 |
| Other Investing Activity | -1,200 | -1,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,015,200 | $-139,800 | $-144,400 | $-55,900 | $-51,500 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 75,000 | 0 | 0 |
| Debt Issued | N/A | 836,600 | 389,000 | 0 | 0 |
| Debt Repayment | N/A | -218,900 | N/A | N/A | -2,300 |
| Common Stock Issued | 11,900 | 194,600 | 10,100 | 10,400 | 19,100 |
| Common Stock Repurchased | N/A | -100,000 | 0 | N/A | N/A |
| Other Financing Activity | -1,200 | -1,900 | -75,000 | -2,300 | 0 |
| Financing Cash Flow | $10,700 | $710,400 | $399,100 | $8,100 | $16,800 |
| Exchange Rate Effect | -700 | 1,800 | 300 | 0 | 0 |
| Beginning Cash Position | 1,137,100 | 441,500 | 94,500 | 86,100 | 71,800 |
| End Cash Position | 446,400 | 1,137,100 | 441,500 | 94,500 | 86,100 |
| Net Cash Flow | $-690,700 | $695,600 | $347,000 | $8,400 | $14,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | 314,500 | 123,200 | 92,000 | 56,200 | 49,000 |
| Capital Expenditure | -180,000 | -67,100 | -66,000 | -55,700 | -33,300 |
| Free Cash Flow | 134,500 | 56,100 | 26,000 | 500 | 15,700 |